WELLINGTON MANAGEMENT GROUP LLP
Position in CATX — Perspective Therapeutics, Inc.
CIK 902219
Boston, MA
Position in CATX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$701,489
-$7,257 QoQ
Shares Held
168,223
-18.6% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0%
Shared 71%
None 29%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $10,802,033,266 across 28 Medical Devices names. CATX ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
27,070,518 | $2,779,330,079 | |
| 2 | SYK |
Stryker Corp
|
8,121,707 | $2,668,711,698 | |
| 3 | EW |
Edwards Lifesciences Corp
|
22,011,101 | $1,762,648,965 | |
| 4 | BSX |
Boston Scientific Corp
|
18,833,406 | $1,181,796,224 | |
| 5 | MDT |
Medtronic plc
|
7,525,572 | $652,090,810 | |
| 6 | STE |
STERIS plc
|
2,873,365 | $635,387,197 | |
| 7 | DXCM |
Dexcom Inc
|
9,326,240 | $585,687,870 | |
| 8 | INSP |
Inspire Medical Systems, Inc.
|
2,535,954 | $130,804,505 |
All Filings in CATX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $701,489 | 168,223 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $708,746 | 206,632 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||